SCHEMBL20004070

SCHEMBL20004070

CC(c1ccc2nccn2c1)N(N)c1nc(-c2ccn(C)c2)cnc1N

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MET P08581 3/20 0.41
NQO2 P16083 1/20 0.41
DYRK1A Q13627 2/20 0.35
JAK2 O60674 1/20 0.34
PIK3CA P42336 2/20 0.33
TGFBR1 P36897 4/20 0.31
KEAP1 Q14145 1/20 0.30
HCRTR2 O43614 1/20 0.30
PIK3CD O00329 1/20 0.30
ABL1 P00519 1/20 0.30
EGFR P00533 1/20 0.30
HCK P08631 1/20 0.30
SRC P12931 1/20 0.30
KDR P35968 1/20 0.30
PIK3CB P42338 1/20 0.30
MTOR P42345 1/20 0.30
PIK3CG P48736 1/20 0.30
EPHB4 P54760 1/20 0.30
PRKDC P78527 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25836231 0.85 MET (0.38) METNQO2DYRK1AJAK2PIK3CA
SCHEMBL22109191 0.85 MET (0.38) METNQO2DYRK1AJAK2PIK3CA
SCHEMBL29317548 0.83 MET (0.37) METNQO2DYRK1AJAK2PIK3CA
SCHEMBL29315788 0.80 MET (0.40) METNQO2DYRK1AJAK2HCRTR2
SCHEMBL29315243 0.78 MET (0.34) METNQO2DYRK1AJAK2PIK3CA
SCHEMBL29314918 0.74 MET (0.36) METNQO2DYRK1AJAK2PIK3CA
SCHEMBL21801854 0.71 MET (0.78) METNQO2
SCHEMBL20004072 0.71 MET (0.78) METNQO2
SCHEMBL30733000 0.71 MET (0.78) METNQO2
SCHEMBL21167598 0.70 MET (0.48) METNQO2HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515418-B1 USE OF C-MET INHIBITORS TO TREAT CANCERS HARBOURING MET MUTATIONS ASTRAZENECA AB (SE) 2021-04-14 EP disclosed
WO-2018055029-A1 USE OF C-MET INHIBITORS TO TREAT CANCERS HARBOURING MET MUTATIONS ASTRAZENECA AB (SE) 2018-03-29 WO disclosed